Legal & Regulatory
51-60 of 402
New England Compounding Center Produced Drugs That Were Superpotent and Subpotent
Quality control manager testifies at deadly meningitis trial that some compounded drugs were too strong, others too weak.
Posted 02/01/17 | 
Legal Update: The Legal Burden of Workplace Bullying
Staff-on-staff hostility puts your facility at risk for litigation.
Posted 01/31/17 | |
As Business Boomed at Compounding Pharmacy, Disinfection Practices Slid
At meningitis trial, pharmacy tech testifies that hoods in clean room where tainted steroids were made weren't disinfected for a month.
Posted 01/25/17 |
Pain Management Doc Takes Stand in Meningitis Murder Trial
Fungal meningitis victims "kept coming," says medical director of pain clinic where 13 patients died and 115 were sickened.
Posted 01/18/17 |
Prosecutor: New England Compounding Center President Viewed Company as His "Personal ATM Machine"
NECC head pharmacist charged with second-degree murder in the deaths of 25 patients.
Posted 01/10/17 |
OSHA Seeking Input on Workplace Violence in Health Care
Posted 01/09/17 |
Legal Update: Double Dose of Good Regulatory News for ASCs
Medicare law promotes pricing transparency and removes EHR penalties.
Posted 01/09/17 | |
Is Medical Direction of CRNAs a Reimbursement Scheme or Safer for Patients?
A point-counterpoint between a nurse anesthetist and an anesthesiologist.
Posted 01/09/17 | |
Trial to Begin for Pharmacist Linked to Deadly Fungal Meningitis Outbreak
Opening arguments set for Monday in trial of Barry Cadden, the owner of the New England Compounding Center.
Posted 01/05/17 |
FDA: Battery-Powered Mobile Medical Carts Could Be a Fire Hazard
The agency has received reports of explosions, fires, smoking and overheating related to lithium batteries.
Posted 01/04/17 |
